Status:
UNKNOWN
Risk of COVID-19 Infection After Vaccination
Lead Sponsor:
Umeå University
Conditions:
Vaccination; Infection
Covid19
Eligibility:
All Genders
Up to 110 years
Brief Summary
The purpose of this observational nationwide study is to evaluate the effects of three different COVID-19 vaccines for the outcome of different severities of incident COVID infection.
Eligibility Criteria
Inclusion
- Living in Sweden and vaccinated with BNT162b2, mRNA-1273 or ChAdOx1
- All individuals with a previous COVID-19 infection
- Controls matched 1:1 to the groups above
Exclusion
- None
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
2000000 Patients enrolled
Trial Details
Trial ID
NCT04848441
Start Date
May 1 2021
End Date
August 1 2021
Last Update
April 19 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.